diabetes

diabetes

Main Page Content

UI hosts dedication ceremony for $126 million Pappajohn Biomedical Discovery Building

Exterior of Pappajohn Biomedical Discovery Building

The University of Iowa will hold a dedication ceremony Wednesday, Oct. 15, for the $126 million John and Mary Pappajohn Biomedical Discovery Building, which will house “high-risk, high-reward” research in diabetes, deafness, and brain science as well as complex diseases affecting the heart and lungs. Media tours start at 3:15 p.m., followed by a dedication program, ribbon-cutting ceremony, and public reception, and tours. Story

Keeping Iowa Healthy - Diabetes Research Center

Dedication of the Fraternal Order of Eagles Diabetes Research CenterUI celebrates the dedication of the Fraternal Order of the Eagles Diabetes Research Center.

In this video, Dale Abel, director of the Fraternal Order of Eagles Diabetes Research Center at the University of Iowa, discusses the mission of this center and how a $25 million dollar gift from the Fraternal Order of Eagles will make new advances and understanding possible in the fight against this devastating disease. Video

UI Children's Hospital nationally ranked by US News & World Report

Rendering of new UI Children's Hospital

U.S. News and World Report has ranked University of Iowa Children’s Hospital in eight out of ten specialty areas in its 2014-15 Best Children’s Hospitals listings. Story

Low birth weight linked to type 2 diabetes in women

African American woman testing her blood glucose levels

New research from the University of Iowa shows that lower birth weight is associated with an increased risk for type 2 diabetes in White and Black postmenopausal women in the U.S. Story

Bacteria and fat: a 'perfect storm' for inflammation, may promote diabetes

Published
2013.10.31

Making fat cells immortal might seem like a bad idea to most people, but for a team of University of Iowa scientists it was the ideal way to study how the interaction between bacteria and fat cells might contribute to diabetes. Story from: Medical Xpress

Medical Xpress

Bacteria and fat: a 'perfect storm' for inflammation

A University of Iowa study shows that bacterial toxins trigger fat cells to produce pro-inflammatory molecules. The findings suggest that by promoting chronic inflammation through their effect on fat cells, bacterial toxins may play a role in the development of diabetes. Story

Fruit takes a bite out of diabetes risk

Published
2013.08.29
apple and grapes

A longitudinal, observational study shows eating more fruit, particularly apples, grapes, and blueberries, lowers type 2 diabetes risk, which fits what clinicians already tell patients about the importance of a healthy diet, said UI endocrinologist Christopher Adams. Story from: MedPage Today

MedPage Today

'The Happy Diabetic' chef cooks it up at the Iowa State Fair

Chef Robert Lewis holding a platter of veggetables

Chef Robert Lewis, "The Happy Diabetic," will demonstrate healthy dishes for diabetics on Aug. 17 at the Iowa State Fair. The demonstration coincides with an effort at the University of Iowa to enroll participants in a national study to identify the most effective drugs to treat type-2 diabetes. Story

Abel named director of the UI Fraternal Order of Eagles Diabetes Research Center

Video of E. Dale Abel, M.D., D.Phil.E. Dale Abel, M.D., D.Phil., has been named the new director of the Fraternal Order of Eagles Diabetes Research Center in the UI Roy J. and Lucille A. Carver College of Medicine. Abel will also hold the John B. Stokes III Chair in Diabetes Research.

The University of Iowa has appointed E. Dale Abel, M.D., D.Phil., as the new director of the Fraternal Order of Eagles Diabetes Research Center in the UI Roy J. and Lucille A. Carver College of Medicine. Abel will also hold the John B. Stokes III Chair in Diabetes Research. Video

UI Hospital and Clinics begins recruitment for long-term study of diabetes drug efficacy

University of Iowa Hospital and Clinics is recruiting volunteers to participate in a study to compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes. Story

Pages

Subscribe to diabetes